Clinical Study
Performance of a New HPV Cervi-Collect Collection and Transportation Kit
Table 1
Agreement between Cervi-Collect and PreservCyt L-Pap specimens tested by the Abbott RealTime HR HPV assay.
| |||||||||||||||||||||||||||
Positive agreement—85.7% (84/98); Negative agreement—88.2% (105/119); Overall agreement—93.1% (189/203) (kappa = 0.86). |